How has been the historical performance of QMS Medical?

Answer:The historical performance of QMS Medical shows significant growth in key financial metrics from March 2024 to March 2025.

Breakdown:
In the fiscal year ending March 2025, QMS Medical reported net sales of 156.01 Cr, an increase from 122.13 Cr in the previous year. Total operating income also rose to 156.01 Cr from 122.13 Cr, while total expenditure increased to 130.60 Cr from 103.78 Cr. Operating profit (PBDIT) improved to 27.13 Cr from 18.81 Cr, leading to a profit before tax of 18.66 Cr, up from 12.24 Cr. The profit after tax saw a rise to 13.70 Cr from 9.00 Cr, resulting in a consolidated net profit of 12.09 Cr compared to 9.00 Cr in the prior year. Earnings per share increased to 6.77 from 5.04, and the operating profit margin improved to 16.29% from 15.02%. On the balance sheet, total assets grew to 189.79 Cr from 135.32 Cr, with total liabilities also increasing to 189.79 Cr from 135.32 Cr. Cash flow from operating activities surged to 20.00 Cr from 1.00 Cr, while cash flow from investing activities saw a significant outflow of -45.00 Cr, compared to -2.00 Cr the previous year. Overall, QMS Medical demonstrated strong financial performance with notable increases in sales, profits, and cash flow.